EA202190894A1 - LIPIDS BASED ON 2,5-DIOXOPIPERAZINE CONTAINING INTERCALATED ESTER, THIOESTER, DISULPHIDE AND ANHYDRIDE FRAGMENTS - Google Patents

LIPIDS BASED ON 2,5-DIOXOPIPERAZINE CONTAINING INTERCALATED ESTER, THIOESTER, DISULPHIDE AND ANHYDRIDE FRAGMENTS

Info

Publication number
EA202190894A1
EA202190894A1 EA202190894A EA202190894A EA202190894A1 EA 202190894 A1 EA202190894 A1 EA 202190894A1 EA 202190894 A EA202190894 A EA 202190894A EA 202190894 A EA202190894 A EA 202190894A EA 202190894 A1 EA202190894 A1 EA 202190894A1
Authority
EA
Eurasian Patent Office
Prior art keywords
dioxopiperazine
thioester
disulphide
ester
lipids based
Prior art date
Application number
EA202190894A
Other languages
Russian (ru)
Inventor
И Чжан
Франк Дероза
Шриран Карв
Майкл Хартлейн
Сасвата Кармакар
Райан Ландис
Original Assignee
Транслейт Био, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Транслейт Био, Инк. filed Critical Транслейт Био, Инк.
Priority claimed from PCT/US2019/060344 external-priority patent/WO2020097384A1/en
Publication of EA202190894A1 publication Critical patent/EA202190894A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Изобретение частично предусматривает липидные соединения на основе циклической аминокислоты формулы (A') и ее подформул или ее фармацевтически приемлемой соли. Соединения, предусмотренные в данном документе, могут быть применимыми для доставки и экспрессии mRNA и кодируемого белка, например, в качестве компонента липосомальной среды-носителя для доставки и, соответственно, могут быть применимыми для лечения разнообразных заболеваний, нарушений и состояний, таких как заболевания, нарушения и состояния, ассоциированные с дефицитом одного или более белков.The invention provides, in part, lipid compounds based on a cyclic amino acid of formula (A ') and sub-formulas thereof, or a pharmaceutically acceptable salt thereof. The compounds provided herein may be useful for the delivery and expression of mRNA and encoded protein, for example, as a component of a liposomal delivery vehicle and, accordingly, may be useful for the treatment of a variety of diseases, disorders and conditions such as diseases, disorders and conditions associated with a deficiency of one or more proteins.

EA202190894A 2019-07-08 2019-11-07 LIPIDS BASED ON 2,5-DIOXOPIPERAZINE CONTAINING INTERCALATED ESTER, THIOESTER, DISULPHIDE AND ANHYDRIDE FRAGMENTS EA202190894A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962871510P 2019-07-08 2019-07-08
PCT/US2019/060344 WO2020097384A1 (en) 2018-11-09 2019-11-07 2,5-dioxopiperazine lipids with intercalated ester, thioester, disulfide and anhydride moieities

Publications (1)

Publication Number Publication Date
EA202190894A1 true EA202190894A1 (en) 2021-10-05

Family

ID=78572600

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202190894A EA202190894A1 (en) 2019-07-08 2019-11-07 LIPIDS BASED ON 2,5-DIOXOPIPERAZINE CONTAINING INTERCALATED ESTER, THIOESTER, DISULPHIDE AND ANHYDRIDE FRAGMENTS

Country Status (1)

Country Link
EA (1) EA202190894A1 (en)

Similar Documents

Publication Publication Date Title
MX2021005482A (en) 2,5-dioxopiperazine lipids with intercalated ester, thioester, disulfide and anhydride moieities.
ATE417610T1 (en) COMPOSITION CONTAINING 6-Ä3-(1-ADAMANTYL)-4-METHOXYPHENYLÜ-2-NAPHTHANOIC ACID FOR THE TREATMENT OF DERMATOLOGICAL DISEASES
MX2023003344A (en) Piperazine-based cationic lipids.
EA200501017A1 (en) ASTHMA AND MODULATORS OF ALLERGIC INFLAMMATION
CY1110318T1 (en) PHAINEOXIC ACID PRODUCERS
CY1108976T1 (en) DIAGNOSTIC AMINOXIC PRODUCTS
NO20054769D0 (en) Substituted phenylalkanoic acids
MX2008001865A (en) Albumin fusion proteins.
MX2009002816A (en) Albumin fusion proteins.
DE60219917D1 (en) NAPHTOQUINONE DERIVATIVES AS INHIBITORS OF TAU AGGREGATION FOR THE TREATMENT OF ALZHEIMER'S AND ASSOCIATED NEURODEEGENERATIVE DISEASES
EA200701828A1 (en) COMPOSITIONS FOR THE TREATMENT OF RETINOL-ASSOCIATED DISEASES
AR113422A2 (en) RECONSTITUTED SURFACTIVE AGENTS HAVING IMPROVED PROPERTIES
MXPA05011524A (en) Substituted carboxylic acids.
BRPI0414868A (en) compositions and methods comprising prostaglandin-related compounds and trifoliate factor family peptides for the treatment of glaucoma with reduced hyperemia
WO2020097376A8 (en) Multi-peg lipid compounds
WO2007071658A3 (en) Alkyl phospholipid derivatives with reduced cytotoxicity and uses thereof
DE602007014210D1 (en) PROPHYLACTIC / THERAPEUTIC AGENT FOR NEURODEGENERATIVE DISEASES
BR112014001017A2 (en) use of one or more nucleotides to improve the heat stability of an aqueous micellar casein composition; liquid nutritional composition; a process for heat treating an aqueous micellar casein composition; and method for providing nutrition to a person in need of this
EA202190310A1 (en) PROTEIN FOR INFLAMMATORY DISEASES
ATE414526T1 (en) PREPARATIONS FOR THE TREATMENT OF ARTHRITIC SYMPTOMS
MX337358B (en) Conjugates of disorazoles and their derivatives with cell-binding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof.
BRPI0608020A2 (en) A process for producing a soy protein-containing composition and a soy protein-containing composition
EA202190894A1 (en) LIPIDS BASED ON 2,5-DIOXOPIPERAZINE CONTAINING INTERCALATED ESTER, THIOESTER, DISULPHIDE AND ANHYDRIDE FRAGMENTS
WO2010023195A3 (en) Compositions and methods for treating cancer
DE602004005821D1 (en) ENTERAL PREPARATION FOR PREVENTING BZW. TREATMENT OF SEPSIS